Comparative efficacy of various pharmacologic treatments for alcohol withdrawal syndrome: a systematic review and network meta-analysis

Abstract

This study was to compare multiple classes of medications and medication combinations to find alternatives or additives for patients not applicable to benzodiazepines (BZDs). We performed a network meta-analysis to assess the comparative effect of 11 pharmacologic treatments in patients with alcohol withdrawal syndrome. Forty-one studies were included, comprising a total sample size of 4187 participants. The pooled results from the randomized controlled trials showed that there was no significant difference in the Clinical Institute Withdrawal Assessment-Alcohol, revised (CIWA-Ar) reduction with other medications or medication combinations compared to BZDs. Compared to BZDs, the mean difference in ICU length of stay of anticonvulsants + BZDs was −1.71 days (95% CI = −2.82, −0.59). Efficacy rankings from cohort studies showed that anticonvulsant + BZDs were superior to other treatments in reducing CIWA-Ar scores and reducing the length of stay in the ICU. Synthesis results from randomized controlled trials indicate that there are currently no data suggesting that other medications or medication combinations can fully replace BZDs. However, synthetic results from observational studies have shown that BZDs are effective in the context of adjuvant anticonvulsant therapy, particularly with early use of gabapentin in combination with BZDs in the treatment of alcohol withdrawal syndrome, which represents a promising treatment option.

Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments

“…Severe cases may have a relevant mortality risk (Long et al, 2017;Wolf et al, 2020), and management is mainly still based on the use of benzodiazepines (Airagnes et al, 2019), although other options may be considered. The systematic review and meta-analysis in this issue compares 11 potential treatments analyzing a series of outcomes (Qu et al, 2023). Results suggest that benzodiazepines, such as diazepam and chlordiazepoxide, are indeed a useful and necessary option, however, other treatments in combination may be beneficial.…”